Literature DB >> 19219621

PHEX analysis in 118 pedigrees reveals new genetic clues in hypophosphatemic rickets.

Céline Gaucher1, Odile Walrant-Debray, Thy-Minh Nguyen, Laure Esterle, Michèle Garabédian, Frédéric Jehan.   

Abstract

Familial hypophosphatemic rickets is a rare disease, which is mostly transmitted as an X-linked dominant trait, and mutations on the phosphate regulating gene with homologies to endopeptidases on the X-chromosome (PHEX) gene are responsible for the disease in most familial cases. In this study we analyzed PHEX in a large cohort of 118 pedigrees representing 56 familial cases and 62 sporadic cases. The high-resolution melting curves technique was tested as a screening method, along with classical sequencing. PHEX mutations have been found in 87% of familial cases but also in 72% of sporadic cases. Missense mutations were found in 16 probands, two of which being associated with other PHEX mutations resulting into truncated proteins. By plotting missense mutations described so far on a 3D model of PHEX we observed that these mutations focus on two regions located in the inner part of the PHEX protein. Family members of 13 sporadic cases were analyzed and a PHEX mutation was detected in one of the apparently healthy mother. These results highlight the major role of PHEX in X-linked dominant hypophosphatemic rickets, and give new clues regarding the genetic analysis of the disease. A screening of the different family members should be mandatory when a PHEX mutation is assessed in a sporadic case and the search for another PHEX mutation should be systematically proceed when facing a missense mutation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19219621     DOI: 10.1007/s00439-009-0631-z

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  34 in total

1.  Developmental expression and tissue distribution of Phex protein: effect of the Hyp mutation and relationship to bone markers.

Authors:  A F Ruchon; H S Tenenhouse; M Marcinkiewicz; G Siegfried; J E Aubin; L DesGroseillers; P Crine; G Boileau
Journal:  J Bone Miner Res       Date:  2000-08       Impact factor: 6.741

2.  Genomic organization of the human PEX gene mutated in X-linked dominant hypophosphatemic rickets.

Authors:  F Francis; T M Strom; S Hennig; A Böddrich; B Lorenz; O Brandau; K L Mohnike; M Cagnoli; C Steffens; S Klages; K Borzym; T Pohl; C Oudet; M J Econs; P S Rowe; R Reinhardt; T Meitinger; H Lehrach
Journal:  Genome Res       Date:  1997-06       Impact factor: 9.043

3.  Mutational analysis of the PEX gene in patients with X-linked hypophosphatemic rickets.

Authors:  I A Holm; X Huang; L M Kunkel
Journal:  Am J Hum Genet       Date:  1997-04       Impact factor: 11.025

4.  Disease-causing missense mutations in the PHEX gene interfere with membrane targeting of the recombinant protein.

Authors:  Y Sabbagh; G Boileau; L DesGroseillers; H S Tenenhouse
Journal:  Hum Mol Genet       Date:  2001-07-15       Impact factor: 6.150

5.  Hereditary hypophosphatemic rickets with hypercalciuria is caused by mutations in the sodium-phosphate cotransporter gene SLC34A3.

Authors:  Bettina Lorenz-Depiereux; Anna Benet-Pages; Gertrud Eckstein; Yardena Tenenbaum-Rakover; Janine Wagenstaller; Dov Tiosano; Ruth Gershoni-Baruch; Norbert Albers; Peter Lichtner; Dirk Schnabel; Ze'ev Hochberg; Tim M Strom
Journal:  Am J Hum Genet       Date:  2005-12-09       Impact factor: 11.025

6.  Three novel PHEX gene mutations in Japanese patients with X-linked hypophosphatemic rickets.

Authors:  K Sato; T Tajima; J Nakae; M Adachi; Y Asakura; K Tachibana; S Suwa; N Katsumata; T Tanaka; Y Hayashi; S Abe; M Murashita; K Okuhara; N Shinohara; K Fujieda
Journal:  Pediatr Res       Date:  2000-10       Impact factor: 3.756

7.  Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23.

Authors: 
Journal:  Nat Genet       Date:  2000-11       Impact factor: 38.330

Review 8.  The wrickkened pathways of FGF23, MEPE and PHEX.

Authors:  Peter S N Rowe
Journal:  Crit Rev Oral Biol Med       Date:  2004-09-01

9.  Information for the Coordinates of Exons (ICE): a human splice sites database.

Authors:  Allen Chong; Guanglan Zhang; Vladimir B Bajic
Journal:  Genomics       Date:  2004-10       Impact factor: 5.736

10.  A common molecular basis for three inherited kidney stone diseases.

Authors:  S E Lloyd; S H Pearce; S E Fisher; K Steinmeyer; B Schwappach; S J Scheinman; B Harding; A Bolino; M Devoto; P Goodyer; S P Rigden; O Wrong; T J Jentsch; I W Craig; R V Thakker
Journal:  Nature       Date:  1996-02-01       Impact factor: 49.962

View more
  39 in total

Review 1.  Genetics of Refractory Rickets: Identification of Novel PHEX Mutations in Indian Patients and a Literature Update.

Authors:  Binata Marik; Arvind Bagga; Aditi Sinha; Pankaj Hari; Arundhati Sharma
Journal:  J Pediatr Genet       Date:  2018-01-28

2.  Mutational analysis of PHEX, FGF23 and DMP1 in a cohort of patients with hypophosphatemic rickets.

Authors:  Mary D Ruppe; Patrick G Brosnan; Kit Sing Au; Phong X Tran; Barbara W Dominguez; Hope Northrup
Journal:  Clin Endocrinol (Oxf)       Date:  2011-03       Impact factor: 3.478

3.  Age-related stature and linear body segments in children with X-linked hypophosphatemic rickets.

Authors:  Miroslav Zivičnjak; Dirk Schnabel; Heiko Billing; Hagen Staude; Guido Filler; Uwe Querfeld; Marius Schumacher; Anke Pyper; Carmen Schröder; Jürgen Brämswig; Dieter Haffner
Journal:  Pediatr Nephrol       Date:  2010-12-01       Impact factor: 3.714

4.  Growth in PHEX-associated X-linked hypophosphatemic rickets: the importance of early treatment.

Authors:  Catherine Quinlan; Katie Guegan; Amaka Offiah; Richard O' Neill; Melanie P Hiorns; Sian Ellard; Detlef Bockenhauer; William Van't Hoff; Aoife M Waters
Journal:  Pediatr Nephrol       Date:  2011-11-20       Impact factor: 3.714

5.  A novel de novo mutation within PHEX gene in a young girl with hypophosphatemic rickets and review of literature.

Authors:  Chong Kun Cheon; Hoon Sang Lee; Su Yung Kim; Min Jung Kwak; Gu-Hwan Kim; Han-Wook Yoo
Journal:  Ann Pediatr Endocrinol Metab       Date:  2014-03-31

Review 6.  Tooth dentin defects reflect genetic disorders affecting bone mineralization.

Authors:  S Opsahl Vital; C Gaucher; C Bardet; P S Rowe; A George; A Linglart; C Chaussain
Journal:  Bone       Date:  2012-01-26       Impact factor: 4.398

7.  Abnormal presence of the matrix extracellular phosphoglycoprotein-derived acidic serine- and aspartate-rich motif peptide in human hypophosphatemic dentin.

Authors:  Tchilalo Boukpessi; Celine Gaucher; Thibaut Léger; Benjamin Salmon; Julie Le Faouder; Cyril Willig; Peter S Rowe; Michèle Garabédian; Olivier Meilhac; Catherine Chaussain
Journal:  Am J Pathol       Date:  2010-06-25       Impact factor: 4.307

8.  Genetic diagnosis of X-linked dominant Hypophosphatemic Rickets in a cohort study: tubular reabsorption of phosphate and 1,25(OH)2D serum levels are associated with PHEX mutation type.

Authors:  Marcos Morey; Lidia Castro-Feijóo; Jesús Barreiro; Paloma Cabanas; Manuel Pombo; Marta Gil; Ignacio Bernabeu; José M Díaz-Grande; Lourdes Rey-Cordo; Gema Ariceta; Itxaso Rica; José Nieto; Ramón Vilalta; Loreto Martorell; Jaime Vila-Cots; Fernando Aleixandre; Ana Fontalba; Leandro Soriano-Guillén; José M García-Sagredo; Sixto García-Miñaur; Berta Rodríguez; Saioa Juaristi; Carmen García-Pardos; Antonio Martínez-Peinado; José M Millán; Ana Medeira; Oana Moldovan; Angeles Fernandez; Lourdes Loidi
Journal:  BMC Med Genet       Date:  2011-09-08       Impact factor: 2.103

Review 9.  Extracellular matrix mineralization in periodontal tissues: Noncollagenous matrix proteins, enzymes, and relationship to hypophosphatasia and X-linked hypophosphatemia.

Authors:  Marc D McKee; Betty Hoac; William N Addison; Nilana M T Barros; José L Millán; Catherine Chaussain
Journal:  Periodontol 2000       Date:  2013-10       Impact factor: 7.589

Review 10.  Hypophosphatemia and growth.

Authors:  Fernando Santos; Rocío Fuente; Natalia Mejia; Laura Mantecon; Helena Gil-Peña; Flor A Ordoñez
Journal:  Pediatr Nephrol       Date:  2012-11-22       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.